nference

nference is a Cambridge, Massachusetts-based company founded in 2013, specializing in augmented intelligence and advanced deep learning to make biomedical data computable and accessible. The company aims to transform healthcare and accelerate biomedical discovery by synthesizing vast amounts of biomedical data, including electronic medical records, scientific literature, and genomic data. The nSights Platform is designed for clinical researchers and data scientists to analyze large-scale biomedical data, while the Agentic AI Platform utilizes multimodal AI agents to personalize care pathways and enhance precision research across various therapeutic areas. nference supports research in cardiology, oncology, immunology, rare diseases, neurology, infectious diseases, and nephrology, contributing to improved patient outcomes. With a strategic partnership with Mayo Clinic and collaborations with biopharma companies, nference leverages biomedical data and AI for drug development and precision medicine. The company operates globally, with offices in Bangalore, Toronto, and Rochester, and is committed to bridging biomedical knowledge with AI to unlock insights and enable next-generation healthcare solutions.